Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lixian Yi"'
Autor:
Peijun Tang, Xingnian Chen, Junchi Xu, Yunlong Hu, Zhijian Ye, Xiafang Wang, Yumei Xiao, Xinghua Shen, Jianping Zhang, Yanjun Feng, Cuilin Shi, Xin Yu, Lixian Yi, Xinchun Chen, Binfeng Lu, Ping Xu, Zhongwen Sun, Meiying Wu
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Objective. Multidrug-resistant tuberculosis (MDR-TB) causes persistent infection and challenges tuberculosis control worldwide. T cell-mediated immunity plays a critical role in controlling Mycobacterium tuberculosis (Mtb) infection, and therefore, e
Externí odkaz:
https://doaj.org/article/e7edf10e63a6427ab59c88d017f0f34c
Autor:
Min Yang, Wenwen Du, Lixian Yi, Shaoxian Wu, Chunyan He, Wensi Zhai, Cuihua Yue, Runzi Sun, Ashley V. Menk, Greg M. Delgoffe, Jingting Jiang, Binfeng Lu
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
The immune checkpoint blockade (ICB) immunotherapy has prolonged overall survival for cancer patients but the response rates are low. The resistance to ICB is likely due to compensatory upregulation of additional immune inhibitory molecules. In this
Externí odkaz:
https://doaj.org/article/f8aee54f31f8445996117a0211295b79
Autor:
Yang Li, David Shihong Gao, Lixian Yi, Fei Gao, Runzi Sun, Kevin Kai Lu, Junchi Xu, Jason Shoush, Zoi Kykrou, Minxin Liang, Binfeng Lu
Recent studies have shown that p53 contributes to poor survival during immune checkpoint blockade (ICB) therapy. Lung cancer patients with p53 mutations have significantly improved response rates to PD-1 ICB therapy. While previous studies have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71479a61311da9212276db9f85cbcf1e
https://doi.org/10.1101/2022.09.11.507505
https://doi.org/10.1101/2022.09.11.507505
Autor:
Binfeng Lu, Wenwen Du, Cuihua Yue, Wensi Zhai, Greg M. Delgoffe, Runzi Sun, Chunyan He, Min Yang, Shaoxian Wu, Jingting Jiang, Lixian Yi, Ashley V. Menk
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Oncoimmunology
Oncoimmunology
The immune checkpoint blockade (ICB) immunotherapy has prolonged overall survival for cancer patients but the response rates are low. The resistance to ICB is likely due to compensatory upregulation of additional immune inhibitory molecules. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98229ddb087660eedfc0c3564f06865a
https://doi.org/10.1080/2162402x.2019.1708064
https://doi.org/10.1080/2162402x.2019.1708064
Autor:
Xinyi Tang, Jie Ma, Kai Yin, Jie Tian, Ke Rui, Dong Shen, Shengjun Wang, Hongsheng Zhu, Lixian Yi, Huaxi Xu
Publikováno v:
Inflammation. 39:759-767
Rheumatoid arthritis (RA) is characterized by chronic synovial inflammation and subsequent joint destruction. Previous studies have confirmed that Th17 cells play a critical role in the pathogenesis of RA. MicroRNA (miR)-301a-3p is a regulatory facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6690128e60cb5093353da04a6b927028
https://doi.org/10.1007/s10753-016-0304-8
https://doi.org/10.1007/s10753-016-0304-8
Autor:
Zhongwen Sun, Caiyun Feng, Hong Tao, Zhenghong Jin, Jingfang Huang, Lixian Yi, Yang Xiao, Jing Sun
Publikováno v:
Central European Journal of Immunology. 2:216-222
Graves’ disease is an autoimmune disease of the thyroid gland mediated by T cells. CD28, a member of costimulatory molecules, plays a pivotal role in regulating T-cell responses. Plasma-soluble CD28 is one form of CD28 in peripheral blood. To inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4395a5da4f5f729aaa7cb5ec18d13347
https://doi.org/10.5114/ceji.2014.43726
https://doi.org/10.5114/ceji.2014.43726